Fat Loss & Muscle Preservation: New Obesity Treatment Pathway

PITTSBURGH, February 6, 2026 – Forget everything you think you know about weight loss. Researchers at the University of Pittsburgh have pinpointed two enzymes that appear to orchestrate fat loss *while* protecting precious muscle mass-a holy grail in the fight against obesity.

A New Pathway to Slimmer,Stronger Bodies

This revelation could pave the way for safer and more effective obesity treatments,moving beyond the often-frustrating cycle of losing muscle alongside fat.

• A study identified two enzymes, CGI-58 and AMPK, as key regulators of fat metabolism and muscle preservation.
• Blocking CGI-58 in mice led to significant fat loss without muscle wasting.
• The research suggests a potential therapeutic target for obesity that avoids the drawbacks of current weight loss methods.
• The findings were published in the journal eLife on February 6, 2026.

Losing weight frequently enough feels like a zero-sum game: shed fat,and you risk losing hard-earned muscle too. But what if you could selectively target fat, leaving muscle untouched? That’s the promise of this new research, which zeroes in on the intricate dance between two enzymes: CGI-58 and AMPK. Understanding this interplay could revolutionize how we approach weight management.

How CGI-58 and AMPK Work Together

Researchers discovered that CGI-58, an enzyme responsible for breaking down fats, works in tandem with AMPK, a crucial energy sensor in cells. when activated, AMPK signals the body to burn fat for fuel. The team found that CGI-58 essentially delivers the fats to AMPK, enabling efficient fat metabolism. But here’s the twist: blocking CGI-58 doesn’t shut down AMPK-it simply redirects the fats, preventing muscle breakdown.

The study, conducted on mice, showed that inhibiting CGI-58 resulted in considerable fat loss-up to 30 percent-without any noticeable decrease in muscle mass. This is a significant departure from typical weight loss interventions.

“We’ve identified a pathway that allows us to selectively target fat, while preserving muscle,” explained lead researcher Dr. Sachin Patel. “This is a major step forward in developing therapies that address the metabolic complications of obesity without the detrimental side effects of muscle loss.”

The Mouse Model and future Directions

The research team conducted their experiments on mice fed a high-fat diet. Mice with CGI-58 inhibited